Blocking of striated muscle degeneration by serotonin in C. elegans

Prevention of muscle fiber degeneration is a key issue in the treatment of muscular dystrophies such as Duchenne Muscular Dystrophy (DMD). It is widely postulated that existing pharmaceutical compounds might potentially be beneficial to DMD patients, but tools to identify them are lacking. Here, by...

Full description

Saved in:
Bibliographic Details
Published inJournal of muscle research and cell motility Vol. 27; no. 3-4; pp. 253 - 258
Main Authors Carre-Pierrat, Maité, Mariol, Marie-Christine, Chambonnier, Lucie, Laugraud, Aurélie, Heskia, Fabienne, Giacomotto, Jean, Ségalat, Laurent
Format Journal Article
LanguageEnglish
Published Netherlands Springer Nature B.V 2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Prevention of muscle fiber degeneration is a key issue in the treatment of muscular dystrophies such as Duchenne Muscular Dystrophy (DMD). It is widely postulated that existing pharmaceutical compounds might potentially be beneficial to DMD patients, but tools to identify them are lacking. Here, by using a Caenorhabditis elegans model of dystrophin-dependent muscular dystrophy, we show that the neurohormone serotonin and some of its agonists are potent suppressors of muscle degeneration. Inhibitors of serotonin reuptake transporters, which prolong the action of endogenous serotonin, have a similar effect. Moreover, reduction of serotonin levels leads to degeneration of non-dystrophic muscles. Our results demonstrate that serotonin is critical to C. elegans striated muscles. These findings reveal a new function of serotonin in striated muscles.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0142-4319
1573-2657
DOI:10.1007/s10974-006-9070-9